Evidence map›Paper›PMID 39996842›Full record

ArticleCurrent issues in molecular biology2025

Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer.

Seda Er Özilhan, Safa Can Efil, Doğukan Çanakçı, Yetkin Ağaçkıran, Didem Şener Dede, Nilüfer Onak Kandemir, Mehmet Doğan, Tuba Dilay Kökenek Ünal, Merve Meryem Kıran, Serra Kayaçetin and 2 more

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Seda Er ÖzilhanDepartment of Pathology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.ORCID 0009-0003-4602-9810
Safa Can EfilDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.ORCID 0000-0001-9586-2858
Doğukan ÇanakçıFaculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.ORCID 0009-0000-9357-3761
Yetkin AğaçkıranDepartment of Pathology, Ankara Atatürk Sanatoryum Hospital, Health Sciences University, Ankara 06290, Turkey.ORCID 0000-0003-1642-3668
Didem Şener DedeDepartment of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.ORCID 0000-0002-9756-5942
Nilüfer Onak KandemirDepartment of Pathology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.
Mehmet DoğanDepartment of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.ORCID 0000-0001-8806-0400
Tuba Dilay Kökenek ÜnalDepartment of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.ORCID 0000-0003-3981-6026
Merve Meryem KıranDepartment of Pathology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.ORCID 0000-0003-2498-0472
Serra KayaçetinDepartment of Pathology, Ankara Bilkent City Hospital, Health Sciences University, Ankara 06290, Turkey.ORCID 0000-0002-2615-0512
Hilal BaltaDepartment of Pathology, Ankara Bilkent City Hospital, Health Sciences University, Ankara 06290, Turkey.ORCID 0000-0003-3745-9694
Hayriye Tatlı DoğanDepartment of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06800, Turkey.ORCID 0000-0003-4318-2775

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIF-1αKRASlung cancerPD-L1

Identifiers

PMID39996842
PMCPMC11854292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.